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We report the atypical case of a nondiabetic 66-year old male with severe abdominal pain and vomiting who was found to have
emphysematous cystitis. Of all gas-forming infections of the urinary tract emphysematous cystitis is the most common and the
least severe. The major risk factors are diabetes mellitus and urinary tract obstruction. Most frequent causative pathogens are
Escherichia coli and Klebsiella pneumoniae. The clinical presentation is nonspeciﬁc and ranges from asymptomatic urinary tract
infection to urosepsis and septic shock. The diagnosis is made by abdominal imaging. Treatment consists of broad-spectrum
antibiotics, bladder drainage, and management of the risk factors. Surgery is reserved for severe cases. Overall mortality rate
of emphysematous cystitis is 7%. Immediate diagnosis and treatment is necessary because of the rapid progression to bladder
necrosis, emphysematous pyelonephritis, urosepsis, and possibly fatal evolution.
1.Introduction
Emphysematous cystitis (EC) is a rare but occasionally
severe clinical problem. Aetiology is multifactorial and
pathogenesis is poorly understood. Most patients diagnosed
with EC are elderly diabetic females. Clinical presentation
varies individually and may not correlate with the degree of
inﬂammation. Rapid recognition and treatment is necessary
to prevent progression to bladder necrosis, emphysematous
pyelonephritis (EP), and urosepsis. We present an atypical
case of EC in a nondiabetic 66-year old male.
2. Case Presentation
A 66-year old schizophrenic male was brought to the
emergency department because of severe abdominal pain
and vomiting for three hours. He was pale, sweating, and
tachypneic. Autoanamnesis was impossible because of his
psychiatric comorbidity but heteroanamnesis told us he had
not mentioned any other complaints.
Besides schizophrenia no other pathology was retained
in his medical history. His daily medication consisted of an
antipsychotic drug, an anticholinergic drug, and a benzo-
diazepine.
Physical exam revealed a body temperature of 37.8◦C,
heart rate of 145 beats per minute, blood pressure of
130/55mmHg, and oxygen saturation of 91%. Oxygen was
administered with a quick increase of the oxygen saturation
to 99%. Palpation of the abdomen was extremely painful
with diﬀuse muscular defence. No other abnormalities were
found. Physical examination was very diﬃcult since patient
was uncooperative.
Laboratory evaluation resulted in a CRP (C-reactive
protein) of 49.47mg/dL (0.00–0.50mg/dL), white blood cell
count of 6.52×103/µL (4.50–11.00×103/µL), prothrombin
time of 59% (75–100%), serum creatinine of 6.0mg/dL
(0.70–1.20mg/dL),BUN(bloodureanitrogen)of217mg/dL
(8–50mg/dL), and an eGFR (estimated glomerular ﬁltra-
tion rate) of 9mL/min (>60mL/min). PSA (prostate spe-
ciﬁc antigen) measured 141ng/mL (<6.9ng/mL). Transam-
inases were augmented: ASAT (aspartate aminotrans-
ferase) 190U/L (5–34U/L), ALAT (alanine aminotrans-
ferase) 118U/L (5–41U/L). Furthermore an LDH (lactate
dehydrogenase) of 605U/L (240–480U/L) and CK (creatine
kinase) of 2206U/L (<200U/L) were found. Blood glucose
level was 113mg/dL (70–110mg/dL).
Macroscopicallyurinewascloudy.Microscopicurinalysis
showed >100 RBC (red blood cell)/HPF (high power ﬁeld),
50–100 WBC (white blood cell)/HPF and some bacteria.
Despite painkillers, the patient continued complaining
of abdominal pain. Because of the severity of his pain,2 Case Reports in Urology
Figure 1: Computed tomography scan of the abdomen showed air in the bladder and the thickened bladder wall, associated with air intra-
and retroperitoneally.
computed tomography scan of the abdomen was performed.
This revealed air in the bladder and the thickened blad-
der wall, associated with air intra- and retroperitoneally.
Furthermore, bilateral pleural ﬂuid, some free ﬂuid in the
peritoneal cavity, and a few dilated jejunal segments without
characteristics of bowel ischemia were seen (Figures 1(a) and
1(b)). The diagnosis of emphysematous cystitis was made.
Broad-spectrum antibiotics (piperacilline-tazobactam)
were empirically started. Intravenous ﬂuid and analgesics
were associated. A transurethral catheter was placed and
patientwasadmittedtothesurgicaldepartment.Afewhours
later he was transferred to the intensive care unit (ICU)
since he became more septic (hypotensive, tachycardiac,
tachypneic) and developed a reddishness of the suprapubic
region (Figure 2). There was no fever.
The following days the patient became less septic, renal
function improved and the abdominal pain decreased.
Contrary to the clinical improvement, the zone of reddish-
ness expanded up to the ﬂanks bilaterally (Figure 3). After
two days this reddishness subsided and patient was again
admitted to the surgical department. Urine culture revealed
more than 106 colonies/mL of Escherichia coli. Intravenous
piperacilline-tazobactam administration was continued.
Despite continuous intravenous antibiotics and bladder
catheterization, patient developed fever (38◦C) one week
after admission. A control computed tomography scan of
the abdomen showed necrosis of the bladder wall, pre-
dominantly the bladder dome and right bladder wall, with
associatedperitonitissigns(Figures4(a)and4(b)).Thesame
day an explorative laparotomy was performed. Compatible
with the computed tomography scan, the bladder dome and
right bladder wall were necrotic and perforated. All necrotic
tissue was resected, both ureteral oriﬁces were visualised
and preserved. The bladder was closed after placement of a
new sterile transurethral catheter. Piperacilline-tazobactam
administration was continued per- and postoperative.
Af e wh o u r sp o s t o p e r a t i v ep a t i e n tb e c a m eh e m o d y n a m -
ically unstable. Chest X-ray and electrocardiogram were
normal. Arterial blood sample showed a haemoglobin level
of 4.7g/dL. Although abdominal drains evacuated no blood
Figure 2: Patient developed a reddishness of thesuprapubic region.
Figure 3: Zone of reddishness expanded up to the ﬂanks bilaterally.
a postoperative bleeding was suspected and patient was
brought to the operating room for an urgent second look.
A venous bleeding of the right iliac vein was visualised and
sutured.Case Reports in Urology 3
Figure 4: Control computed tomography scan of the abdomen showed necrosis of the bladder wall, predominantly the bladder dome and
right bladder wall, with associated peritonitis signs.
Afterwardspatientwassedated,intubated,andventilated
forseveraldaysontheICU.Hissituationgraduallyimproved
and ten days later he was again admitted to the surgical
department with the transurethral catheter in situ. Antibi-
otics were switched to quinolones (levoﬂoxacin).
A cystography three weeks postoperatively showed some
contrast extravasation into the space of Retzius (Figures 5(a)
and 5(b)). Consequently the transurethral catheter was left
in situ.
Levoﬂoxacin administration was ceased after a sterile
urine culture 25 days postoperatively.
Two weeks later patient left the hospital with the
transurethral catheter in situ, which he himself promptly
removedonthethirddayfollowinghisdischarge.Afterwards
no voiding problems were seen so no new drainage was
provided. A control cystography one week later revealed no
contrast leakage anymore (Figure 6). Patient was comfort-
able, voiding was uncomplicated with good voiding volumes
and no residual volume, and patient was again discharged.
Pathology report of the partial cystectomy specimen
showed only necrotic tissue, Gram- and PAS staining (peri-
odic acid-Schiﬀ)w e r en e g a t i v e .
3. Discussion
EC is an infection of the bladder associated with gas
production, usually occurring in elderly diabetic females.
Thomas et al. [1] identiﬁed that two-thirds of all reported
cases of EC until 2006 were diabetic and 64% were women,
withamedianpatientageof66years.IntheseriesofGrupper
et al. [2] the same percentages were found. Kuo et al. [3]
also found a predilection of EC for women, according to
them due to an increased susceptibility of women to urinary
tractinfections.Incontrasttotheseﬁndingswepresentedthe
atypical case of a 66-year old nondiabetic male.
The aetiology and pathogenesis of EC remain poorly
understood. In diabetic patients an elevated tissue and
urinary glucose level is a plausible source of fermentation for
gas-forming bacteria. This process is possibly favoured by
associated impaired renal perfusion, diabetic nephropathy,
bladder dysfunction secondary to neuropathy, and impaired
leukocyte function. In non-diabetic patients higher levels
of urinary albumin, lactose, or tissue proteins can result in
the formation of H2 (hydrogen) and CO2 (carbon dioxide)
gas. In all cases it concerns an inappropriate host response
to the causative microorganism. Urinary tract obstruction,
and consequently urinary stasis, is another major risk
factor besides diabetes. All patients with recurrent urinary
tract infections, indwelling urethral catheter, neurogenic
bladder, immunosuppressive comorbidity, and others. are
predisposed to complicated UTIs (urinary tract infection)
such as EC. Grupper et al. [2] found an incidence of
malignancy of 8% associated with EC in their series, Kuo
et al. [3] found an association with malignancy in 16.7%. No
otherreportsofmalignanciesassociatedwithECwerefound.
Clinical features of EC are nonspeciﬁc and vary indi-
vidually. Some patients are asymptomatic or report only
minor voiding problems or abdominal pain, while others
present with septic shock. Thomas et al. [1] found that
7% of the reported cases in literature were asymptomatic
and diagnosed incidentally by abdominal imaging for other
concurrent conditions. A recent study of Kuo et al. [3]
showed no signiﬁcant clinical manifestation suggesting the
presence of EC. Furthermore clinical presentation does
not correlate with the severity of inﬂammation. Grupper
et al. [2] reported that classic symptoms of UTI were
seen in only approximately 50% of the cases. The most
common symptom in their series was abdominal pain. EC is
a possibly life-threatening disease because of rapid progres-
sion to bladder necrosis, EP, urosepsis, and death. To avoid
these complications prompt evaluation and treatment is
necessary.
Since clinical presentation of EC is very diﬀerent and
nonspeciﬁc, EC is diagnosed radiologically. Most accurate
examination is the computed tomography scan of the
abdomen/pelvis [1–3]. Because of the increased use of
computed tomography scan, a greater incidence of emphy-
sematous infections is seen. Other important factors for this4 Case Reports in Urology
Figure 5: A cystography three weeks postoperatively showed some contrast extravasation into the space of Retzius.
Figure 6: A control cystography six weeks postoperatively revealed
no contrast leakage anymore.
are a greater awareness for such pathology and an increase in
number of diabetic and elderly patients. As not all patients
with symptoms of urinary tract infection are submitted to
abdominal imaging, the number of cases may be underesti-
mated. Thomas et al. [1] found that computed tomography
scan was used in 40% of the cases of EC until 2006. Simple
plain ﬁlm of the abdomen was the most common imaging
method, used in 84%. An abdominal X-ray has a very low
speciﬁcity however. Kuo et al. [3] found that simple radio-
graph of the abdomen was diagnostic in only 13%. Com-
puted tomography scan also diﬀerentiates other pathology
associatedwithairintheurinarytract(i.e.,uro-intestinalﬁs-
tulae, renal infarction, trauma, instrumentation). Moreover
the presence of EP can be evaluated. Computed tomography
scan in our case showed air in the bladder lumen, the
bladder wall, the peritoneal cavity, and the retroperitoneal
space. The combination of presence of air in all these com-
partments is by our knowledge never been reported in the
literature before. Abdominal ultrasound and MRI (magnetic
resonance imaging) are less valuable as imaging modalities
because of diﬃcult interpretation. Cystoscopy alone is not
suﬃcient to diagnose EC but it can evaluate the presence of
bladder outlet obstruction. A pathological assessment typi-
cally reveals a thickened bladder wall with multiple gas-ﬁlled
vesicles, predominantly in the bladder mucosa, surrounded
by ﬂattened ﬁbrocytes and multinucleated giant cells
[4, 5].
Multiple gas-producing microorganisms can cause EC.
Escherichia coli, Klebsiella pneumonia, Enterococcus, Candida,
Clostridium perfringens, and many others were all isolated
in urinary culture, with Escherichia coli being the most
prevalent followed by Klebsiella pneumonia [1–3]. The same
pathogens were found in cases of EP [3, 6, 7]. Most
organisms are facultative anaerobic, only in rare cases a pure
anaerobic isolate, multiple organisms, or no organisms are
found.
The management of EC generally consists of broad-
spectrum antibiotics, bladder drainage, correction of the
blood glucose level, and treatment of any underlying comor-
bid disorders. In most cases broad-spectrum antibiotics
are started. Once the sensitivities of the isolated urinary
pathogensareknown,antibioticsshouldbeswitchedtomore
speciﬁc ones. No consensus exists about the duration of
antibiotic treatment. Grupper et al. [2] found a median
length of ten days, the median length of hospital stay was
seven days. In severe cases, or if the patient does not
respond to conservative treatment, surgery is needed (partial
cystectomy, cystectomy, surgical debridement). In the series
of Thomas et al. 10% [1] of the patients underwent surgery.
In the series of Grupper et al. [2] 15% needed a laparotomy.
This group needing surgery was not signiﬁcantly diﬀerent
from the nonsurgical group for demographic or comorbidity
parameters. Postoperatively, antibiotic treatment, bladder
drainage and control of blood glucose level, and other risk
factors should be continued.
Thomas et al. [1] published an overall mortality rate of
EC of 7%. In the series of Grupper et al. [2] a mortality rate
of 9.4% was found. This indicates that EC can be successfully
treated with conservative management alone and is not as
severe as feared. When another emphysematous infection of
the urinary tract is associated the mortality rate increases
to14% [1]. No other signiﬁcant predictors of poor outcome
were identiﬁed.Case Reports in Urology 5
4. Conclusions
Emphysematous cystitis is an uncommon infectious con-
dition of the bladder caused by gas-producing micro-
organismsBecauseofthepossibleinsidiousclinicalpresenta-
tionitisofutmostimportancethatemergencyphysiciansare
aware of this clinical entity, especially in high risk patients.
Immediate diagnosis and treatment is necessary because of
the rapid progression to bladder necrosis, EP, urosepsis, and
possibly fatal evolution.
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